信诺 2026年季度报告

☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June30, 2026 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number 001-38769 The Cigna Group(Exact name of registrant as specified in its charter) 82-4991898 900 Cottage Grove RoadBloomfield,Connecticut06002(Address of principal executive offices) (Zip Code) (860)226-6000(Registrant's telephone number, including area code) Not Applicable(Former name, former address and former fiscal year, if changed since last report) Securities registered pursuant to Section 12(b) of the Act: Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2) has been subject to such filing requirements for the past 90 days.☒Yes☐No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required tosubmit such files).☒Yes☐No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reportingcompany," and "emerging growth company" in Rule 12b-2 of the Exchange Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).☐Yes☒No As of July24, 2026, 264,240,486 shares of the issuer's Common Stock were outstanding. THE CIGNA GROUP TABLE OF CONTENTS PagePART IFINANCIAL INFORMATIONItem 1.Financial Statements (Unaudited)3Consolidated Statements of Income3Consolidated Statements of Comprehensive Income4Consolidated Balance Sheets5Consolidated Statements of Changes in Total Equity6Consolidated Statements of Cash Flows8Notes to the Consolidated Financial Statements9Item 2.Management's Discussion and Analysis of Financial Condition and Results of Operations30Item 3.Quantitative and Qualitative Disclosures About Market Risk43Item 4.Controls and Procedures43PART IIOTHER INFORMATIONItem 1.Legal Proceedings44Item 1A.Risk Factors44Item 2.Unregistered Sales of Equity Securities and Use of Proceeds44Item 5.Other Information44Item 6.Exhibits45SIGNATURE46 As used herein, the term "Company" refers to one or more of The Cigna Group and its consolidated subsidiaries. Part I.FINANCIAL INFORMATIONItem 1.FINANCIAL STATEMENTS The Cigna GroupConsolidated Statements of Income THE CIGNA GROUP TABLE OF CONTENTS Note NumberFootnote BUSINESS ANDCAPITALSTRUCTURE1Description of Business2Summary of Significant Accounting Policies3Accounts Receivable, Net4Supplier Finance Program5Earnings Per Share6DebtINSURANCEINFORMATION7Insurance and Contractholder Liabilities8ReinsuranceINVESTMENTS9Investments10Fair Value Measurements11Accumulated Other Comprehensive Income (Loss)WORKFORCEMANAGEMENT ANDCOMPENSATION12Strategic Optimization ProgramCOMPLIANCE, REGULATION ANDCONTINGENCIES13Income Taxes14Contingencies and Other MattersRESULTSDETAILS15Segment Information Note 1 – Description of Business The Cigna Group , together with its subsidiaries (either individually or collectively referred to as the "Company," "we," "us" or "our"),is a global health company committed to creating a better future for every individual and every community. Powered by our dedicatedpeople and valued brands, we advance our mission to improve the health and vitality of those we serve.® Our subsidiaries offer a differentiated set of pharmacy, medical, behavioral, dental, and related products and services. The majority ofthese products and services are offered through employers and other entities, such as governmental and nongovernmentalorganizations, unions and associations. Certain subsidiaries also offer health and dental insurance products to individuals in the UnitedStates and select international markets. In addition to these operations, The Cigna Group also has certain run-off operations. A full description of our segments follows: TheEvernorth Health Services reportable segment includes the Pharmacy Benefit Services and the Specialty and Care Servicesoperating segments, which provide independent and coordinated health solutions and capabilities to enable the health care system towork better and help people live healthier lives.® Pharmacy Benefit